Myriad Genetics Stock Options Expiring on 19th of July
| MYGN Stock | USD 22.14 0.16 0.72% |
Myriad Genetics' latest option contracts expiring on 2024-07-19 are carrying combined implied volatility of 51.01 with a put-to-call open interest ratio of 0.3 over 40 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-07-19.
Open Interest Against 2024-07-19 Option Contracts
2024-07-19
The chart above shows Myriad Genetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Myriad Genetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Myriad Genetics' option, there is no secondary market available for investors to trade.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. Please note that buying 'in-the-money' options on Myriad Genetics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Myriad Genetics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Myriad Genetics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Myriad Stock moves the wrong way.
At this time, Myriad Genetics' Liabilities And Stockholders Equity is very stable compared to the past year. As of the 9th of June 2024, Other Stockholder Equity is likely to grow to about 1.5 B, while Total Stockholder Equity is likely to drop about 541.5 M. Myriad Genetics In The Money Call Balance
When Myriad Genetics' strike price is surpassing the current stock price, the option contract against Myriad Genetics stock is said to be in the money. When it comes to buying Myriad Genetics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Myriad Genetics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Myriad Current Options Market Mood
Myriad Genetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Myriad Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Myriad Genetics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Myriad Genetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Myriad Genetics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Myriad contract
Base on the Rule 16, the options market is currently suggesting that Myriad Genetics will have an average daily up or down price movement of about 3.19% per day over the life of the 2024-07-19 option contract. With Myriad Genetics trading at USD 22.14, that is roughly USD 0.71. If you think that the market is fully incorporating Myriad Genetics' daily price movement you should consider buying Myriad Genetics options at the current volatility level of 51.01%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Myriad |
Myriad Genetics Option Chain
When Myriad Genetics' strike price is surpassing the current stock price, the option contract against Myriad Genetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Myriad Genetics' option chain is a display of a range of information that helps investors for ways to trade options on Myriad. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Myriad. It also shows strike prices and maturity days for a Myriad Genetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-07-19 CALL at $15.0 | 0.8326 | 0.0212 | 0 | 2024-07-19 | 6.8 - 9.3 | 0.0 | In |
Call | 2024-07-19 CALL at $16.0 | 0.8108 | 0.0258 | 0 | 2024-07-19 | 5.7 - 8.4 | 0.0 | In |
Call | 2024-07-19 CALL at $17.0 | 0.7807 | 0.0309 | 0 | 2024-07-19 | 5.0 - 7.3 | 0.0 | In |
Call | 2024-07-19 CALL at $18.0 | 0.763 | 0.04 | 0 | 2024-07-19 | 3.9 - 6.1 | 0.0 | In |
Call | 2024-07-19 CALL at $19.0 | 0.7095 | 0.0448 | 0 | 2024-07-19 | 3.4 - 5.3 | 0.0 | In |
Call | 2024-07-19 CALL at $20.0 | 0.7002 | 0.0752 | 245 | 2024-07-19 | 2.55 - 3.0 | 3.0 | In |
Call | 2024-07-19 CALL at $21.0 | 0.6117 | 0.093 | 0 | 2024-07-19 | 1.8 - 2.2 | 0.0 | In |
Call | 2024-07-19 CALL at $23.0 | 0.3957 | 0.1031 | 2 | 2024-07-19 | 0.75 - 1.15 | 0.05 | Out |
Put | 2024-07-19 PUT at $24.0 | -0.6799 | 0.0885 | 0 | 2024-07-19 | 1.95 - 4.1 | 0.0 | In |
Put | 2024-07-19 PUT at $25.0 | -0.9381 | 0.041 | 69 | 2024-07-19 | 2.7 - 3.4 | 1.75 | In |
Put | 2024-07-19 PUT at $29.0 | -0.7898 | 0.0412 | 0 | 2024-07-19 | 6.4 - 7.9 | 0.0 | In |
Put | 2024-07-19 PUT at $30.0 | -0.8631 | 0.0338 | 0 | 2024-07-19 | 7.3 - 8.6 | 0.0 | In |
Put | 2024-07-19 PUT at $31.0 | -0.7566 | 0.0345 | 0 | 2024-07-19 | 8.3 - 10.2 | 0.0 | In |
Put | 2024-07-19 PUT at $32.0 | -0.8467 | 0.03 | 0 | 2024-07-19 | 9.3 - 10.7 | 0.0 | In |
Put | 2024-07-19 PUT at $33.0 | -0.8723 | 0.026 | 0 | 2024-07-19 | 10.3 - 11.6 | 0.0 | In |
Put | 2024-07-19 PUT at $35.0 | -0.9145 | 0.0178 | 0 | 2024-07-19 | 12.4 - 14.5 | 0.0 | In |
Myriad Total Stockholder Equity
Total Stockholder Equity |
|
Myriad Genetics Corporate Management
| Nicole Lambert | Chief Officer | Profile | |
| Clivetty Martinez | Chief Officer | Profile | |
| Pamela Wong | Chief Officer | Profile | |
| Shereen Solaiman | Chief Officer | Profile |
Additional Information and Resources on Investing in Myriad Stock
When determining whether Myriad Genetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myriad Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myriad Genetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myriad Genetics Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myriad Genetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share 9.114 | Quarterly Revenue Growth 0.116 | Return On Assets (0.07) | Return On Equity (0.29) |
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.